These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15770496)

  • 1. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.
    Gödde R; Rohde K; Becker C; Toliat MR; Entz P; Suk A; Müller N; Sindern E; Haupts M; Schimrigk S; Nürnberg P; Epplen JT
    J Mol Med (Berl); 2005 Jun; 83(6):486-94. PubMed ID: 15770496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
    Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
    Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers.
    Goedde R; Sawcer S; Boehringer S; Miterski B; Sindern E; Haupts M; Schimrigk S; Compston A; Epplen JT
    Hum Genet; 2002 Sep; 111(3):270-7. PubMed ID: 12215840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients.
    Ban M; Sawcer SJ; Heard RN; Bennetts BH; Adams S; Booth D; Perich V; Setakis E; Compston A; Stewart GJ
    J Neuroimmunol; 2003 Oct; 143(1-2):60-4. PubMed ID: 14575915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenetics of multiple sclerosis.
    Svejgaard A
    Immunogenetics; 2008 Jun; 60(6):275-86. PubMed ID: 18461312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for simple and accurate identification of the multiple sclerosis associated allele HLA-DRB1*1501 in neuroscience research laboratories.
    Cisneros E; Moraru M; de Pablo R; Vilches C
    J Neuroimmunol; 2010 Aug; 225(1-2):143-8. PubMed ID: 20493561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk alleles for multiple sclerosis identified by a genomewide study.
    ; Hafler DA; Compston A; Sawcer S; Lander ES; Daly MJ; De Jager PL; de Bakker PI; Gabriel SB; Mirel DB; Ivinson AJ; Pericak-Vance MA; Gregory SG; Rioux JD; McCauley JL; Haines JL; Barcellos LF; Cree B; Oksenberg JR; Hauser SL
    N Engl J Med; 2007 Aug; 357(9):851-62. PubMed ID: 17660530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.
    Kikuchi S; Fukazawa T; Niino M; Yabe I; Miyagishi R; Hamada T; Hashimoto SA; Tashiro K
    Neurology; 2003 Feb; 60(4):647-51. PubMed ID: 12601107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association and linkage of juvenile MS with HLA-DR2(15) in Russians.
    Boiko AN; Gusev EI; Sudomoina MA; Alekseenkov AD; Kulakova OG; Bikova OV; Maslova OI; Guseva MR; Boiko SY; Guseva ME; Favorova OO
    Neurology; 2002 Feb; 58(4):658-60. PubMed ID: 11865153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of DR2-LUM haplotype generation and the DRB6*0202 linkage to DRB1*1601.
    Corell A; Varela P; Morales P; Paz-Artal E; Martínez-Laso J; Martín-Villa JM; du Toit E; Arnaiz-Villena A
    Immunogenetics; 1993; 38(6):460-1. PubMed ID: 8406620
    [No Abstract]   [Full Text] [Related]  

  • 13. Infectious mononucleosis-linked HLA class I single nucleotide polymorphism is associated with multiple sclerosis.
    Jafari N; Broer L; Hoppenbrouwers IA; van Duijn CM; Hintzen RQ
    Mult Scler; 2010 Nov; 16(11):1303-7. PubMed ID: 20736246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44.
    Kenealy SJ; Herrel LA; Bradford Y; Schnetz-Boutaud N; Oksenberg JR; Hauser SL; Barcellos LF; Schmidt S; Gregory SG; Pericak-Vance MA; Haines JL
    Genes Immun; 2006 Jan; 7(1):73-6. PubMed ID: 16341055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA and multiple sclerosis.
    Martin R; Vogt AB; Kropshofer H; Lichtenfels R
    Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis for clinical expression in multiple sclerosis.
    Barcellos LF; Oksenberg JR; Green AJ; Bucher P; Rimmler JB; Schmidt S; Garcia ME; Lincoln RR; Pericak-Vance MA; Haines JL; Hauser SL;
    Brain; 2002 Jan; 125(Pt 1):150-8. PubMed ID: 11834600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.
    Bronson PG; Caillier S; Ramsay PP; McCauley JL; Zuvich RL; De Jager PL; Rioux JD; Ivinson AJ; Compston A; Hafler DA; Sawcer SJ; Pericak-Vance MA; Haines JL; ; Hauser SL; Oksenberg JR; Barcellos LF
    Hum Mol Genet; 2010 Jun; 19(11):2331-40. PubMed ID: 20211854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
    Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
    Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.